title: CTLA4Ig introduced by adenovirus vector locally to prolong the survival of xenogeneic skin grafts on rat burn wounds.
abstract: BACKGROUND
  The purpose of this study was to explore an applicable approach for prolonging the survival of heterogenetic skin grafts on burn wounds with CTLA4Ig.
  
  
  METHODS
  An adenovirus vector named Ad-CTLA4Ig, which could express human CTLA4Ig fusion protein, was constructed. Infecting and replicating in 293 cells, more Ad-CTLA4Ig and recombinant human CTLA4Ig (rhCTLA4Ig) were prepared, respectively. In a rat flame thermal injury model, the effect of rhCTLA4Ig on survival time of human skin graft on the eschar-excised rat burn wound was observed. Meanwhile, the efficiency of Ad-CTLA4Ig infecting cultured skin fibroblasts, keratinocytes, and partial-thickness skin samples were checked by CTLA4Ig expression essay. Then, the Ad-CTLA4Ig was administered locally on the eschar-excised wound and dermis of the skin graft, and the survival time of the human skin graft on burn wound was measured. The influence of the systemic immune function by rhCTLA4Ig and Ad-CTLA4Ig were also determined.
  
  
  RESULTS
  The prepared rhCTLA4Ig from the supernatant of Ad-CTLA4Ig-infected 293 cells was verified by sodium dodecyl sulfate polyacrylamide gel electrophoresis sodium dodecyl sulfate poly-acrylamide gel electrophoresis and Western blot. It was found that CTLA4Ig could significantly prolong the xenogeneic skin graft survival in a dosage-dependent manner. Interestingly, the survival time was longer when CTLA4Ig was used 24 hours posttransplantation than that at hour 0. The expression of CTLA4Ig could be observed in the cultured skin fibroblasts, keratinocytes, and skin pieces soon after Ad-CTLA4Ig transfection, as demonstrated by either immunocellular chemistry or immunohistochemistry assay. When Ad-CTLA4Ig was locally administered during skin transplantation on burn wound, the survival time was increased from 7.9 days of control group to 21.6 days, whereas the systemic immune function was not affected.
  
  
  CONCLUSIONS
  Administration of Ad-CTLA4Ig locally could prolong the survival time of xenogeneic skin graft on burn wound without significantly influencing the systemic immune function.
authors.affiliation: Burn Research Institute, Southwestern Hospital, Third Military Medical University, Chongqing, China.
authors.forename: Gaoxing
authors.initials: G
authors.lastname: Luo
authors.forename: Jun
authors.initials: J
authors.lastname: Wu
authors.forename: Xiwei
authors.initials: X
authors.lastname: Chen
authors.forename: WeiFeng
authors.initials: W
authors.lastname: He
authors.forename: Shaoxuan
authors.initials: S
authors.lastname: Yi
authors.forename: Zhijie
authors.initials: Z
authors.lastname: Xie
authors.forename: Junshong
authors.initials: J
authors.lastname: Zheng
authors.forename: Jin
authors.initials: J
authors.lastname: Zhu
mesh_terms: D000069594:Abatacept; D000256:Adenoviridae; D000818:Animals; D002056:Burns / Q000276:immunology / Q000378:metabolism / Q000601:surgery*; D002478:Cells, Cultured; D005822:Genetic Vectors; D006084:Graft Rejection / Q000517:prevention & control; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage* / Q000378:metabolism; D007150:Immunohistochemistry; D007155:Immunologic Factors / Q000008:administration & dosage*; D015603:Keratinocytes / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D011994:Recombinant Proteins; D016038:Skin Transplantation; D014162:Transfection; D014183:Transplantation, Heterologous
chemical_list: D018796:Immunoconjugates; D007155:Immunologic Factors; D011994:Recombinant Proteins; D000069594:Abatacept